Dioxoimidazolidine-3-acetate → 5-Hydroxy-1-(3-nitrobenzyl)-2,4-dioxoimidazolidine-3-acetic acid

HRID 1416398Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1416398
[O:1]=C1CNC(=O)N1CC([O-])=O.[N+:12]([C:15]1[CH:16]=[C:17]([CH:31]=[CH:32][CH:33]=1)[CH2:18][N:19]1[C:23](=[O:24])[C:22](=[O:25])[N:21]([CH2:26][C:27]([OH:29])=[O:28])[C:20]1=S)([O-:14])=[O:13]>Cl.O1CCOCC1>[OH:24][CH:23]1[N:19]([CH2:18][C:17]2[CH:31]=[CH:32][CH:33]=[C:15]([N+:12]([O-:14])=[O:13])[CH:16]=2)[C:20](=[O:1])[N:21]([CH2:26][C:27]([OH:29])=[O:28])[C:22]1=[O:25]

Komponenten

5

Versuchsvorschrift

The above-prepared dioxoimidazolidine-3-acetate product of paragraph (2) (3.6 g) was dissolved in a mixed solvent of 4N hydrochloric acid and dioxane and the solution was stirred at room temperature for six hours. The reaction solution was concentrated in vacuo to dryness and then chloroform was added to the residue. The crystals were dislodged from the wall of the reaction flask with a spatula. The solid was collected by filtration, washed with chloroform and dried to give 0.8 g of 5-hydroxy-1-(3-nitrobenzyl)-2,4-dioxoimidazolidine-3-acetic acid [Compound 14] as amorphous crystals. The melting point, MS, IR, NMR, and elementary analysis for the compound were:

Aufarbeitung

  1. concentrationThe reaction solution was concentrated in vacuo to dryness
  2. additionchloroform was added to the residue
  3. filtrationThe solid was collected by filtration
  4. washwashed with chloroform
  5. customdried

Quellen und Nachweise

ORD-Eintrag
ord-d44e976853a54eb69ddafa30fea329b5
Quelldatensatz
uspto-grants-1999_06
Patentnummer
US05912261

Notizen zur Reaktion

Wird geladen…